[1] Liu WK, Fu Q, Li YM, et al. The relationship between cyclooxygenase 2, CD44v6, and nm23H1 in esophageal squamous cell carcinoma[J]. Onkologie, 2009, 32(10): 574-578.
[2] 张海明, 李著. 三维适形放疗与手术治疗可手术食管癌患者110例远期生存分析[J]. 临床研究, 2011, 8(31): 57-59.
[3] 万仁平, 彭瑞薇, 温军机, 等. 术中植入125I放射性粒子辅助治疗老年胸段食管癌的临床研究[J]. 中华实用诊断与治疗杂志, 2009, 23(7): 683-684.
[4] 徐驯宇, 陈前顺, 梁玮, 等. 胸腹腔镜与开胸手术治疗早期食管癌的临床疗效对比[J]. 第二军医大学学报, 2012, 33(7): 799-802.
[5] Nagpal K, Ahmed K, Vats A, et al. Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta analysis[J]. Surg Endosc, 2010, 24(7): 1621-1629.
[6] Biere SS, Cuesta MA, vander Peet DL. Minimally invasiveversus open esophagectomy for cancer: a systematic review and metaanalysis[J]. Minerva Chir, 2009, 64(2): 121-133.
[7] 张志庸. 早期食管癌诊疗新进展[J]. 中华临床医师杂志, 2009, 3(8): 1231-1237.
[8] Zhang HL, Chen LQ, Liu RL, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumornodemetastasis classification for esophageal squamous cell carcinoma[J]. Dis Esophagus, 2009, 23(1): 53-58.
[9] 方文涛, 陈文虎. 食管癌的外科治疗[J]. 医师进修杂志, 2005, 28(4): 1-4. |